Torres, Gabriel Fernando
Alarcón, Brigitte Alejandra
Reyes-Sanchez, Juan Manuel http://orcid.org/0000-0003-0806-7173
Castaño-Gamboa, Natalia http://orcid.org/0000-0001-7383-6800
Buitrago, Giancarlo
Funding for this research was provided by:
Pfizer (2021-237)
Article History
Received: 6 October 2023
Accepted: 24 June 2024
First Online: 2 July 2024
Declarations
:
: This study was approved by the Ethics Committee of the Faculty of Medicine of Universidad Nacional de Colombia, Act 008, May 12th, 2022. All datasets used in this study were provided by the Colombian Ministry of Health to Universidad Nacional de Colombia for research purposes and is available under authorization of the Ministry. All data are stored in secure servers at the Faculty of Medicine. All identification data were removed before being delivered to the Instituto de Investigaciones Clínicas. Data from single individuals were identified using an anonymized identifier provided by the Ministry of Health.
: Not applicable.
: Alarcon A, Castano N and Reyes JM are paid employees of Pfizer (Colombia). Buitrago G has received research contracts through the National University of Colombia from Pfizer, Baxter, Roche, Amgen and Glaxo-Smith-Kline. He also has been sponsored for attendance of academic events by Amgen and Pfizer. Torres G has received research contracts through the National University of Colombia from Pfizer, Roche, Amgen and Glaxo-Smith-Kline. He also has been sponsored for attendance of academic events by Roche.